The average length of stay for soft tissue disorder cases in Canadian hospitals is projected to increase steadily from 2024 to 2028. The forecast predicts a rise from 12.8 days in 2024 to 13.8 days by 2028. Comparing the year-on-year changes, there is a 2.3% increase in 2025, a 1.5% rise in 2026, followed by 2.3% for both 2027 and 2028. The compound annual growth rate (CAGR) from 2024 to 2028 is around 1.9%.
Future trends to watch for include:
- Technological advancements in medical treatments which may impact hospital stays.
- Healthcare policy changes influencing hospital management and patient care efficiency.
- Increased focus on outpatient care and home-based recovery solutions potentially reducing inpatient lengths of stay.
Our readers also like:
Forecast: Musculo-Skeletal System Medicine Sales in the UK
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in the UK
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Germany
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Global Musculo-Skeletal System Medicine Sales by Country
- Million US Dollars
- 2023
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in France
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Germany
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Italy
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Germany
- Units (Hospital Discharges)
- 2024 to 2028
- ReportLinker Research
Global Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases by Country
- Units (Hospital Discharges)
- 2023
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Systemic Connective Tissue Disorders Cases in Canada
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in the UK
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Germany
- Percent of Total Sales
- 2024 to 2028
- ReportLinker Research
Forecast: Musculo-Skeletal System Medicine Sales in Canada
- Million US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Deforming Dorsopathies and Spondylopathies in France
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in Germany
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Average Length of Stay for Soft Tissue Disorders Cases in Germany
- Days
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Deforming Dorsopathies and Spondylopathies Cases in France
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research
Forecast: Hospital Discharges for Systemic Connective Tissue Disorders in Canada
- Units (Hospital Discharges) Per Hundred Thousand Persons
- 2024 to 2028
- ReportLinker Research